We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Integrated DNA Technologies Logo

Integrated DNA Technologies

For more than 35 years, Integrated DNA Technologies have been enabling genomics laboratories with an oligonucleotide manufacturing process unlike anyone else in the industry, with the most advanced synthesis, modification, purification and quality control capabilities available.

Latest Content

Blue digital screen displaying DNA base sequences representing next-generation sequencing (NGS).
Product News

Integrated DNA Technologies and Hamilton Partner To Automate Customizable NGS Workflows and Accelerate Biomarker Discovery

IDT and Hamilton partner to automate NGS workflows, boosting cancer research efficiency and genomic discoveries.
Digital drug capsule with circuit patterns releasing glowing particles, symbolizing AI.
Industry Insight

AI and Synthetic Biology: Balancing Innovation With Biosecurity

AI is revolutionizing biotechnology innovation, but industry stakeholders must work together to mitigate its risks. In this article, Adam Clore explores the role of nucleic acid biosecurity screening tools and how they can be improved.
Sample collection tube with blue cap over a stylized DNA helix and futuristic purple-blue biotech background
Product
Advertisement

HPLC-Purified CRISPR gRNAs

Get more efficient CRISPR editing when HPLC purification and stabilizing modifications are added to your gRNAs. Perfect for more sensitive, pre-clincial editing applications.
An adult holding a baby's hand, signifying the first patient to receive a customized gene therapy was a child.
Industry Insight

How the First Customized Gene Therapy Was Created in Six Months

We spoke with the developers and manufacturers of the CRISPR gene therapy used to treat KJ Muldoon’s rare genetic condition, CPS1, about how the product was created in just six months.
A page with the letters of DNA bases on with a DNA molecule on top.
Product News

Integrated DNA Technologies Bolsters Comprehensive Genomic Profiling Solutions With Launch of New Archer™ HRD Technology for Cancer Research

Archer CGP research assays now enable homologous recombination deficiency (HRD) assessment for identification of key biomarkers critical for cancer research.
Double helix structure of DNA.
Product News

Integrated DNA Technologies Announces New Licensing Agreement With SeQure Dx To Advance CRISPR-Based Therapeutics

Strategic activation unites best-in-class technology with end-to-end development solutions to optimize therapeutic development process.
Influenza A.
Product News

Integrated DNA Technologies Announces New Primers and Probe Set To Identify H5N1 Avian Influenza

PCR/qPCR solution will support surveillance and monitoring of the current H5N1 strain of bird flu in response to multi-state outbreak in U.S. dairy cows.
Double helix structure of DNA with a piece cut out.
Product News

Integrated DNA Technologies Opens New Therapeutic Manufacturing Facility

Expanded footprint, new capabilities mark IDT’s entrance into CRISPR therapeutics space.
A DNA molecule with part of the structure broken off.
Product News

Integrated DNA Technologies and Aldevron® Activate Strategic Partnership

Under the new agreement, Integrated DNA Technologies (IDT) will sell Aldevron cGMP-manufactured CRISPR nucleases to enable customers to rapidly transition from discovery to clinic.
DNA double helix scribbles.
Article

The Potential for Groundbreaking Discoveries With CRISPR Screening

In this article, we consider various platforms to modulate gene expression and the potential of CRISPR-Cas systems to understand and treat diseases, from cancers and congenital disorders to overcoming the growing prevalence of antimicrobial resistance.
Advertisement